
MedX Health 2025 YEAR REVIEW
MedX Health 2025 YEAR REVIEW

MedX Health 2025 YEAR REVIEW
Theralase cancels $4.5M placement, arranges placement
MyndTec Inc. Completes Ninth Tranche of Non-Brokered Private Placement
Bausch + Lomb allocates $2.8B to refinance term loans
Nurexone prepares small-scale manufacturing for ExoPTEN
Theralase(R) Commences Non-Brokered Private Placement and Termination of Previously Announced Financing
Bausch + Lomb Announces Refinancing of Outstanding Term B Loans
Ventripoint, NVHA to develop model for AI heart care
NurExone Plans Small-Scale of ExoPTEN Clinical Manufacturing in Preparation for FUTURE First in Human USE Pathways
Mindbio closes $1.1-million private placement
Healthcare AI Exits Pilot Phase, Enters Production Deployment
Devonian Health Group Reports Financial Results of its First Quarter Ended on October 31, 2025 and Provides Corporate Update
Ventripoint Unveils a Global Model for A.I.-Enhanced Heart Care through Partnership with the Nisga'a Valley Health Authority
MindBio Raises $1.1 Million in Private Placement
Pharmacorp Rx enters deal to acquire pharmacy files